Showing results (1461-1470 of 10,441) with videos related to
Sort By:
Pageof 1,045
AIDS (London, England)|September 13, 2000
Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmidsJ D Boyer, A D Cohen, K E Ugen, et al.AIDS (London, England)|September 13, 2000
HIV-1 subtype H near-full length genome reference strains and analysis of subtype-H-containing inter-subtype recombinantsW Janssens, T Laukkanen, M O Salminen, et al.AIDS (London, England)|September 13, 2000
Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials GroupAIDS (London, England)|September 13, 2000
A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I)K E Squires, R Gulick, P Tebas, et al.AIDS (London, England)|September 13, 2000
The changing impact of HIV/AIDS on Kenyatta National Hospital, Nairobi from 1988/89 through 1992 to 1997G Arthur, S M Bhatt, D Muhindi, et al.AIDS (London, England)|September 13, 2000
Monitoring the AIDS epidemic using HIV prevalence data among young women attending antenatal clinics: prospects and problemsB Zaba, T Boerma, R WhiteAIDS (London, England)|September 12, 2000
Structural interventions in public healthK M Blankenship, S J Bray, M H MersonAIDS (London, England)|September 12, 2000
Structural and environmental HIV prevention for gay and bisexual menD WohlfeilerAIDS (London, England)|August 17, 1999
AIDS vaccine research in Asia: needs and opportunities. Report from a UNAIDS/WHO/NIID meeting Tokyo, 28-30 October 1998AIDS (London, England)|August 17, 1999
Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapyC Piketty, E Race, P Castiel, et al.Pageof 1,045